Summary:
Researchers are currently conducting a series of clinical studies, called the ORAL trials, for patients with active rheumatoid arthritis (RA) at more than 350 locations across 35 countries worldwide. The ORAL trials are part of a large Phase 3 clinical trial program designed to test the effectiveness and safety of the investigational drug CP-690,550, which is an oral pill for patients with RA.
The ORAL trials are made up of six different clinical trials. Should you decide to enroll, your study doctor will tell you which of the six trials is best for you, according to your treatment history.
|
Qualified Participants Must:
• Be 18 years of age or older
•
Diagnosed with active Rheumatoid Arthritis by a medical professional
•
Be willing to follow a study treatment plan, routinely scheduled study visits and other study tests and procedures.
Qualified Participants May Receive:
Study-related medical care, including visits with a rheumatologist at no cost.
|